These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10976506)

  • 1. Conformations in solution and bound to bacterial ribosomes of ketolides, HMR 3647 (telithromycin) and RU 72366: a new class of highly potent antibacterials.
    Evrard-Todeschi N; Gharbi-Benarous J; Gaillet C; Verdier L; Bertho G; Lang C; Parent A; Girault JP
    Bioorg Med Chem; 2000 Jul; 8(7):1579-97. PubMed ID: 10976506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of ketolide, conformations of RU 004 in solution and bound to bacterial ribosomes.
    Bertho G; Gharbi-Benarous J; Delaforge M; Lang C; Parent A; Girault JP
    J Med Chem; 1998 Aug; 41(18):3373-86. PubMed ID: 9719590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lincomycin and clindamycin conformations. A fragment shared by macrolides, ketolides and lincosamides determined from TRNOE ribosome-bound conformations.
    Verdier L; Bertho G; Gharbi-Benarous J; Girault JP
    Bioorg Med Chem; 2000 Jun; 8(6):1225-43. PubMed ID: 10896103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
    Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
    J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance peptides: interaction of peptides conferring macrolide and ketolide resistance with Staphylococcus aureus ribosomes: conformation of bound peptides as determined by transferred NOE experiments.
    Verdier L; Gharbi-Benarous J; Bertho G; Mauvais P; Girault JP
    Biochemistry; 2002 Apr; 41(13):4218-29. PubMed ID: 11914067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site.
    Douthwaite S; Champney WS
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():1-8. PubMed ID: 11566971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging new generation of antibiotic: ketolides.
    Zhong P; Shortridge V
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
    Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS
    J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of erm(C) expression by noninducing antibiotics.
    Bailey M; Chettiath T; Mankin AS
    Antimicrob Agents Chemother; 2008 Mar; 52(3):866-74. PubMed ID: 18086834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA.
    Liu M; Douthwaite S
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1629-33. PubMed ID: 12019067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketolide agents HMR 3004 and HMR 3647 (telithromycin) inhibit the growth of Plasmodium falciparum in vitro.
    Makgatho M; Maimela E; Mbajiorgu F
    Afr Health Sci; 2015 Dec; 15(4):1271-6. PubMed ID: 26958030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of macrolides and ketolides with the phagocytic cell line PLB-985.
    Abdelghaffar H; Soukri A; Babin-Chevaye C; Labro MT
    J Chemother; 2003 Aug; 15(4):350-6. PubMed ID: 12962363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
    Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2003 Mar; 51(3):497-511. PubMed ID: 12615850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.
    Xiong L; Shah S; Mauvais P; Mankin AS
    Mol Microbiol; 1999 Jan; 31(2):633-9. PubMed ID: 10027979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telithromycin: the first of the ketolides.
    Shain CS; Amsden GW
    Ann Pharmacother; 2002 Mar; 36(3):452-64. PubMed ID: 11895060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments on ketolides and macrolides.
    Wu YJ; Su WG
    Curr Med Chem; 2001 Dec; 8(14):1727-58. PubMed ID: 11562291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.